Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BAY987517
- Development stage
- Phase 1
- Lead developer
- Bayer
- Modality
- Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
BAY987517 is a sunscreening agent developed by Bayer. It has been evaluated in clinical studies for its efficacy as a sun protection factor (SPF) agent on human skin. The trials focused on measuring the minimal erythema dose (MED) and minimal persistent pigment darkening dose (MPPD) to assess its protective effects against UVB and UVA radiation, respectively. The studies included healthy volunteers aged 18–70 years with various Fitzpatrick skin types[1][2]. No information is available regarding its specific active ingredient, chemical structure, or detailed mechanism of action beyond its use as a topical sunscreening product.
- Brand names
- Coppertone
- Other names
- BAY 987517BAY987517BAY-987517Coppertone
Beyond the preview
Go deeper on BAY987517.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BAY987517.